Signal Peptide Website
Search my Protein
Advanced Search
Database Search
References
Hints
Links
Imprint
Signal Peptide Database - Viruses
Entry Details
ID
914
Source Database
UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number
Q69024 (Created: 1998-12-15 Updated: 2009-01-20)
UniProtKB/Swiss-Prot Entry Name
VGLB_GPCMV
Protein Name
Glycoprotein B
Gene
GB
Organism Scientific
Guinea pig cytomegalovirus (strain 22122 / ATCC VR682)
Organism Common
GPCMV
Lineage
Viruses
dsDNA viruses, no RNA stage
Herpesvirales
Herpesviridae
Betaherpesvirinae
Protein Length [aa]
901
Protein Mass [Da]
102240
Features
Type
Description
Status
Start
End
signal peptide
potential
1
34
chain
Glycoprotein B
35
901
transmembrane region
potential
714
734
transmembrane region
potential
737
757
topological domain
Extracellular
potential
35
713
topological domain
Cytoplasmic
potential
758
901
glycosylation site
N-linked (GlcNAc...)
potential
53
53
glycosylation site
N-linked (GlcNAc...)
potential
60
60
glycosylation site
N-linked (GlcNAc...)
potential
66
66
glycosylation site
N-linked (GlcNAc...)
potential
197
197
glycosylation site
N-linked (GlcNAc...)
potential
270
270
glycosylation site
N-linked (GlcNAc...)
potential
289
289
glycosylation site
N-linked (GlcNAc...)
potential
328
328
glycosylation site
N-linked (GlcNAc...)
potential
372
372
glycosylation site
N-linked (GlcNAc...)
potential
398
398
glycosylation site
N-linked (GlcNAc...)
potential
406
406
glycosylation site
N-linked (GlcNAc...)
potential
436
436
glycosylation site
N-linked (GlcNAc...)
potential
537
537
glycosylation site
N-linked (GlcNAc...)
potential
571
571
glycosylation site
N-linked (GlcNAc...)
potential
623
623
SP Length
34
----+----1----+----2----+----3----+----4----+----5
Signal Peptide
MRPVRGIARSRILSCSWRGTWTSALTILYLGVYC
Sequence
MRPVRGIARSRILSCSWRGTWTSALTILYLGVYC
ESTTVTPTTVEDTTVS
NG
N
HSDASR
N
NTVIR
N
LTASVDFSQRKLYPYRICSMSMGTDLVRFARTIQ
CVPFNPRVNSEEGIMLIYKRNILPYVFTAYTYQKELLFQRSYKYVTYDYL
LGYSREFVALPMWEIFLVNSRGQCYTSHQRVIGADRYIAYHNDNEV
N
ETM
WLMRDDMGNDDTYRYITVKEHARTPGSVWLYKETCSMNCIVTKTKGKSKF
PYDMFVLPSGVIVNISPFY
N
GSNGKTFREQREKFHIWS
N
YSILKDFGSRA
LEARIVPKMAFYEREDVVIGWEVNDQS
N
VTCEMILWETVDRAIRTEYENA
FHYVARTLTSTFVENKYSPDN
N
LTEDDIKCFKNDAQKKIEEVFLRDY
N
ET
YDMDG
N
ATYHVTTGGLVIVWQGLKQKSLKALEIAA
N
ESAVSATGSNSRRK
RSLPDESTGDISYAQLQFAYDTLRTYINQALGHIAEAWCLDQKRTAEVLH
ELSKINPSNILSAIFGVPVAARVVGDVISLAKCIEV
N
QSTVLIKGDMRKF
SDDGKLEGCYSRPVVWFSMK
N
STEVRLGQLGEDNEILLGTHRMETCQTQD
YRIFVAGDIGYEFQQYVFTKKI
N
LSEIDIIDTMIALKTEPLENIDFKVLE
LYSRDELAQANVFDLESIMREYNYQKKRLDFVVERVINPIPPALKGLDEM
MNGMGAIGKGIGE
AVGAVGGAIGSFIGALVTFVT
NP
FGAFVVFLFCVGCI
TLVITVY
RRQRRAMQRPFDYFFPYASQTITSSVADSSIAVAYPGPEGTSG
DAPPPYPGEAPYGYKDLSVDADTRVSSSSAGAGADFNEEDAVRMLRAIKR
LDDKKRQEIEKSSKDSASNKNSETRRRPGIMDRLRRRGGYQKLNTEDDVH
V
Original
MRPVRGIARSRILSCSWRGTWTSALTILYLGVYCESTTVTPTTVEDTTVS
NGNHSDASRNNTVIRNLTASVDFSQRKLYPYRICSMSMGTDLVRFARTIQ
CVPFNPRVNSEEGIMLIYKRNILPYVFTAYTYQKELLFQRSYKYVTYDYL
LGYSREFVALPMWEIFLVNSRGQCYTSHQRVIGADRYIAYHNDNEVNETM
WLMRDDMGNDDTYRYITVKEHARTPGSVWLYKETCSMNCIVTKTKGKSKF
PYDMFVLPSGVIVNISPFYNGSNGKTFREQREKFHIWSNYSILKDFGSRA
LEARIVPKMAFYEREDVVIGWEVNDQSNVTCEMILWETVDRAIRTEYENA
FHYVARTLTSTFVENKYSPDNNLTEDDIKCFKNDAQKKIEEVFLRDYNET
YDMDGNATYHVTTGGLVIVWQGLKQKSLKALEIAANESAVSATGSNSRRK
RSLPDESTGDISYAQLQFAYDTLRTYINQALGHIAEAWCLDQKRTAEVLH
ELSKINPSNILSAIFGVPVAARVVGDVISLAKCIEVNQSTVLIKGDMRKF
SDDGKLEGCYSRPVVWFSMKNSTEVRLGQLGEDNEILLGTHRMETCQTQD
YRIFVAGDIGYEFQQYVFTKKINLSEIDIIDTMIALKTEPLENIDFKVLE
LYSRDELAQANVFDLESIMREYNYQKKRLDFVVERVINPIPPALKGLDEM
MNGMGAIGKGIGEAVGAVGGAIGSFIGALVTFVTNPFGAFVVFLFCVGCI
TLVITVYRRQRRAMQRPFDYFFPYASQTITSSVADSSIAVAYPGPEGTSG
DAPPPYPGEAPYGYKDLSVDADTRVSSSSAGAGADFNEEDAVRMLRAIKR
LDDKKRQEIEKSSKDSASNKNSETRRRPGIMDRLRRRGGYQKLNTEDDVH
V
----+----1----+----2----+----3----+----4----+----5
Hydropathies
Home
Imprint
© 2007-2017
Dr. Katja Kapp
, Kassel &
thpr.net e. K.
, Dresden, Germany, last update 2010-06-11
